Yun Dai Email and Phone Number

Yun Dai, MD/PhD, MS in Clinical and Translational Sciences, Professor, the First Hospital of Jilin University. His research has been supported by NSFC, NIH RO1, R21, Myeloma SPORE, and Lymphoma SPORE , as well as by multiple awards from MMRF, LLS, etc. He is active members of AACR, ASH, and ISEH. He has published ~90 original research papers and 13 reviews in peer-reviewed journals, and 8 books or chapters. His research has led to several multi-institutional and NCI-supported phase I or II clinical trials in treatment of patients with leukemia, lymphoma, myeloma, and other hematologic malignancies.Dr. Dai’s research interest and expertise are focused on cancer biology and precision medicine.戴云，MD/PhD，现任吉林大学第一医院教授。2015年获VCU临床和转化医学硕士学位。研究方向为癌症精准医学，主要从事肿瘤多组学、表观遗传学、分子靶标和生物标志物、小分子靶向药物和免疫治疗及治疗策略的基础、转化和临床研究，期间发表论文100篇，其中研究论著87篇，综述13篇，撰写8部专著或章节，9篇论文受邀分别在AACR、ASH、EHA、IMW年会作口头报告，8项研究成果已进入临床I/II期试验。研究工作分别获得NSFC、NIH RO1，R21，Myeloma SPORE，Lymphoma SPORE，MMRF，V Foundation、LLS等的资助。现任美国癌症研究学会（AACR）、美国血液病学会(ASH)、国际实验血液学会（ISEH）正式会员(Active Member)。研究领域为肿瘤生物学和精准医学。